Amerise Bioscience Peer Comparison

BSE: 531681

₹0.84

₹-0.02 (-2.33%)

As on 04-Nov-2026IST

Market cap

₹6 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

--

P/B Ratio

1.1

Div. Yield

0 %

Edit

	Amerise Bioscience	Innovassynth Inv	Wealth First	Welspun Inv	Kiran Vyapar
Market cap (₹ Cr)	6	1,438	872	724	532
Revenue (₹ Cr)	0	176	53	7	107
Net Profit (₹ Cr)	-0.07	12.39	27.57	3.38	11.63
Net Margin (%)	-53.23	6.88	44.73	46.88	10.87
RoE (%)	-1.24	10.11	17.65	0.29	0.10
Price to Earnings	--	116.09	31.29	214.31	235.94
Price-To-Book	1.05	8.37	5.28	0.43	0.23

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Amerise Bioscience	Innovassynth Inv	Wealth First	Welspun Inv	Kiran Vyapar
Operating Income	0.08	176.33	52.60	7.20	106.87
Other Income	0.05	3.57	9.05	0.01	0.13
Total Income	0.19	0.00	60.07	5.26	118.70
Interest Expense	0.00	7.25	0.03	0.00	39.01
PBT & Exceptional Items	-0.07	13.96	38.14	4.53	17.95
Operating Expenses	0.19	157.48	23.47	2.68	50.04
Exceptional Income/Expenses	0.00	-0.61	0.00	0.00	0.00
Profit before Tax	-0.07	6.57	37.43	4.53	17.68
Taxes	0.00	-5.82	9.86	1.15	6.05
Profit after Tax	-0.07	12.39	27.57	3.38	11.63
Minority Interest	0.00	0.00	0.28	0.00	0.36
Share of Associate	0.00	0.00	0.00	0.00	-9.73
Consolidated Profit	-0.07	12.38	27.86	3.38	2.26

Liabilities (₹ Cr)

	Amerise Bioscience	Innovassynth Inv	Wealth First	Welspun Inv	Kiran Vyapar
Shareholder's Funds	5.26	171.74	165.11	1,679.33	2,343.01
Minority Interest	0.00	0.00	0.28	0.00	0.36
Non-Current Liabilities	0.00	13.38	0.82	165.97	118.37
Current Liabilities	1.56	103.50	11.00	0.01	532.61
Total Liabilities	8.46	48.60	147.18	820.01	2,598.39

Assets (₹ Cr)

	Amerise Bioscience	Innovassynth Inv	Wealth First	Welspun Inv	Kiran Vyapar
Non-Current Assets	6.77	157.26	28.69	0.00	7.39
Current Assets	0.05	120.53	132.72	1,845.28	3,022.63
Total Assets	8.46	48.60	147.18	820.01	2,598.39
Contingent Liabilities	--	1.05	--	10.70	22.84

Cashflow (₹ Cr)

	Amerise Bioscience	Innovassynth Inv	Wealth First	Welspun Inv	Kiran Vyapar
Cash From Operating Activities	3.07	-0.73	12.33	-1.52	-68.22
Cash Flow from Investing Activities	-3.07	--	6.57	1.53	-23.01
Cash from Financing Activities	--	0.77	-21.00	--	190.13
Net Cash Inflow / Outflow	0.00	0.04	-2.09	0.00	98.90

Ratios

Profitability Ratios

	Amerise Bioscience	Innovassynth Inv	Wealth First	Welspun Inv	Kiran Vyapar
ROCE (%)	0.15	-9.93	36.64	0.83	4.49
ROE (%)	-1.24	10.11	17.65	0.29	0.10
ROA (%)	-0.87	7.32	15.48	0.25	0.40
EBIT Margin (%)	-140.51	6.16	54.02	62.78	52.93
Net Margin (%)	-53.23	6.88	44.73	46.88	10.87
Cash Profit Margin (%)	--	0.00	0.00	70.57	0.00

Growth Ratios

	Amerise Bioscience	Innovassynth Inv	Wealth First	Welspun Inv	Kiran Vyapar
Revenue Growth (%)	-68.65	37.90	-9.89	38.54	2.77
EBIT Growth (%)	-296.43	185.88	-33.84	2.22	32.44
Net Profit Growth (%)	-265.00	202.06	-13.83	0.69	94.12
EPS Growth (%)	-265.00	137.25	-15.94	1.03	-87.41
Book Value Growth (%)	0.11	17.10	8.66	59.32	10.43

Valuation Ratios

	Amerise Bioscience	Innovassynth Inv	Wealth First	Welspun Inv	Kiran Vyapar
Price / Earnings	-86.09	96.15	31.29	214.71	237.81
Price / Book Value	1.08	8.25	5.42	0.43	0.23
Dividend Yield (%)	0.00	0.00	1.59	0.00	0.51
EV/EBITDA	-50.99	79.97	29.88	159.27	5.83
Market Cap (₹ Cr)	--	--	942.38	296.03	502.81

Solvency Ratios

	Amerise Bioscience	Innovassynth Inv	Wealth First	Welspun Inv	Kiran Vyapar
Debt to Equity	0.00	0.02	0.00	0.00	0.00
Short term debt to equity ratio	--	0.10	--	--	0.09
Current Ratio	0.03	1.16	12.07	2,30,659.50	5.68
Quick Ratio	0.03	0.55	10.91	2,30,659.50	5.68
Interest Coverage	39.00	1.91	1,170.69	--	1.45

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly